Filter posts

Registration for BIO's Spring IP Counsels Committee Conference is now OPEN!

Tired of those pea-coats and earmuffs? Wish you were lying on a beach right now, …

Will the PTAB Be A Roadblock for Biotech? Stories from Sessions at BIO 2016

We’re at the beginning of day 3 here at BIO 2016, and that means we’ve already had …

"II Ca-Be-lly, or Not II Ca-Be-lly?”: Is The Famous Cabilly II Antibody Patent Near Extinction?

Guest post by Konstantin Linnik, Ph.D., Isaac Hubner, Ph.D, and Lana Gladstein, who are attorneys …

Here are the Facts about the IPR Kill Rate

FiercePhrma recently ran an article repeating a dubious analysis of the crisis caused by the …

102 Organizations Urge Congress to Maintain a Strong Patent System and Protect Innovation

A diverse group of more than 100 national and state-based advocacy organizations have united to …

CNBC Commentary: Hedge funds, 'reverse trolls' crushing biopharma innovation

Patents are the lifeblood of medical innovation. They are the cornerstone that enables companies to …

2015 BIO World Congress Will Hold Workshops Focusing on Current Investment Trends

BIO recently announced the schedule of workshops for the 2015 World Congress on Industrial Biotechnology. These workshops …

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

Sen Menendez Asks SEC to Investigate IPR Abuses

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate …

11 Days Until BIO 2015: IP Networking and Meetup Opportunities

This year’s BIO International Convention is fast approaching, with plenty of opportunities for the best …